Covered recipient · General Payments record
KATHRYN EMILY HARVEY-FELDEWERTH
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2021–2024
$952.46
- Reported across 55 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $445.76 | 35 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $163.58 | 20 |
| Lilly USA, LLC | $88.02 | 4 |
| ABBVIE INC. | $35.51 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $28.72 | 1 |
| Hologic Sales and Service, LLC | $24.59 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.53 | 1 |
| Sumitomo Pharma America, Inc. | $15.58 | 1 |
| Acerta Pharma LLC | $15.39 | 1 |
| GlaxoSmithKline, LLC. | $15.01 | 1 |
| Amgen Inc. | $14.68 | 1 |
| Exact Sciences Corporation | $13.65 | 1 |
| Hikma Pharmaceuticals USA | $13.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (35)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $20.87 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103887875 | CMS |
| ABBVIE INC. | $14.64 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103887877 | CMS |
| Amgen Inc. | $14.68 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111595538 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.39 | 03/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105569015 | CMS |
| Exact Sciences Corporation | $13.65 | 02/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114695056 | CMS |
| GlaxoSmithKline, LLC. | $15.01 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116410493 | CMS |
| Hikma Pharmaceuticals USA | $13.50 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1127504556 | CMS |
| Hologic Sales and Service, LLC | $24.59 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1084890953 | CMS |
| Lilly USA, LLC | $23.06 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076801 | CMS |
| Lilly USA, LLC | $16.35 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135124041 | CMS |
| Lilly USA, LLC | $19.54 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135094423 | CMS |
| Lilly USA, LLC | $29.07 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135076803 | CMS |
| Novartis Pharmaceuticals Corporation | $28.72 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086960281 | CMS |
| PFIZER INC. | $7.63 | 03/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131458689 | CMS |
| PFIZER INC. | $4.84 | 04/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131452958 | CMS |
| PFIZER INC. | $15.88 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131459440 | CMS |
| PFIZER INC. | $5.23 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131453644 | CMS |
| PFIZER INC. | $4.49 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131526658 | CMS |
| PFIZER INC. | $4.12 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131559979 | CMS |
| PFIZER INC. | $6.24 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131558047 | CMS |
| PFIZER INC. | $6.79 | 06/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131576726 | CMS |
| PFIZER INC. | $13.30 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131502737 | CMS |
| PFIZER INC. | $3.32 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131545816 | CMS |
| PFIZER INC. | $6.69 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131572297 | CMS |
| PFIZER INC. | $2.22 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131575097 | CMS |
| PFIZER INC. | $13.54 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131517233 | CMS |
| PFIZER INC. | $13.78 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131583211 | CMS |
| PFIZER INC. | $19.70 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131580989 | CMS |
| PFIZER INC. | $5.06 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131513872 | CMS |
| PFIZER INC. | $7.61 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131513042 | CMS |
| PFIZER INC. | $8.42 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131535688 | CMS |
| PFIZER INC. | $5.35 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131525660 | CMS |
| PFIZER INC. | $9.37 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131520797 | CMS |
| Sumitomo Pharma America, Inc. | $15.58 | 12/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148862377 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $17.53 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137572182 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.